Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later

View ORCID ProfileChristopher J Gill, Lawrence Mwananyanda, William MacLeod, Geoffrey Kwenda, Rachel Pieciak, Lauren Etter, Daniel J. Bridges, Chilufya Chikoti, Sarah Chirwa, Charles Chimoga, Leah Forman, Ben Katowa, View ORCID ProfileRotem Lapidot, James Lungu, Japhet Matoba, Gift Mwinga, Benjamin Mubemba, Zachariah Mupila, Walter Muleya, Mulenga Mwenda, Benard Ngoma, Ruth Nkazwe, Diana Nzara, Natalie Pawlak, Lillian Pemba, Ngonda Saasa, Edgar Simulundu, Baron Yankonde, Donald M. Thea
doi: https://doi.org/10.1101/2022.03.08.22272087
Christopher J Gill
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher J Gill
  • For correspondence: cgill@bu.edu
Lawrence Mwananyanda
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William MacLeod
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey Kwenda
3University of Zambia, School of Health Sciences, Department of Biomedical Sciences, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Pieciak
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Etter
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Bridges
4Program for Applied Technology in Health (PATH), Malaria Control and Elimination Partnership for Africa, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chilufya Chikoti
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Chirwa
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Chimoga
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Forman
5Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Katowa
6Macha Research Trust, Choma, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rotem Lapidot
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rotem Lapidot
James Lungu
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Japhet Matoba
6Macha Research Trust, Choma, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gift Mwinga
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Mubemba
7Copperbelt University, School of Natural Resources, Department of Wildlife Sciences, Kitwe, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachariah Mupila
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Muleya
8University of Zambia, School of Veterinary Medicine, Department of Biomedical Sciences, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mulenga Mwenda
8University of Zambia, School of Veterinary Medicine, Department of Biomedical Sciences, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benard Ngoma
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Nkazwe
2Avencion Limited, Lusaka, Zambia
9University Teaching Hospital, Department of Microbiology, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Nzara
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Pawlak
10Tufts University school of Medicine, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lillian Pemba
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ngonda Saasa
8University of Zambia, School of Veterinary Medicine, Department of Biomedical Sciences, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edgar Simulundu
6Macha Research Trust, Choma, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baron Yankonde
2Avencion Limited, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald M. Thea
1Boston University School of Public Health, Department of Global Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Sparse data documenting the impact of COVID-19 in Africa has fostered the belief that COVID-19 ‘skipped Africa’. We previously published results from a systematic postmortem surveillance at a busy inner-city morgue in Lusaka, Zambia. Between June-October 2020, we detected COVID-19 in 15-19% of all deaths and concentrated in community settings where testing for COVID-19 was absent. Yet these conclusions rested on a small cohort of 70 COVID-19+ decedents. Subsequently, we conducted a longer and far larger follow-on survey using and expanding on the same methodology.

Methods We obtained a nasopharyngeal swab from each enrolled decedent and tested these using reverse transcriptase quantitative PCR (RT-qPCR). A subset of samples with a PCR cycle threshold <30 underwent genotyping to identify viral lineages. We weighted our results to adjust for enrolment ratios and stratified them by setting (facility vs. community), time of year, age, and location.

Results From 1,118 enrolled decedents, COVID-19 was detected among 32.0% (358/1,116). We observed three waves of transmission that peaked in July 2020, January 2021, and ∼June 2021 (end of surveillance). These were dominated by the AE.1 lineage and the Beta and Delta variants, respectively. During peak transmission, COVID-19 was detected in ∼90% of all deaths. Roughly four COVID-19 deaths occurred in the community for every facility death. Antemortem testing occurred for 52.6% (302/574) of facility deaths but only 1.8% (10/544) of community deaths and overall, only ∼10% of COVID-19+ deaths were identified in life.

Conclusions COVID-19 had a devastating impact in Lusaka. COVID-19+ deaths occurred in all age groups and was the leading cause of death during peak transmission periods. Testing was rarely done for the vast majority of COVID-19 deaths that occurred in the community, yielding a substantial undercount.

What is already known on this topic

  • Previously, we reported that COVID-19 was present among 15-19% of all decedents passing through a busy city morgue in Lusaka.

  • Data documenting the mortal impact of COVID-19 in Africa remain sparse.

  • Several modeling groups have also argued that COVID-19’s impact in Africa has been underreported and hence underestimated.

What this study adds

  • Antemortem testing for COVID-19 captured only ∼10% of COVID-19 positive individuals indicating a substantial gap in surveillance.

  • During peak transmission periods, ∼90% of all deceased individuals tested positive for COVID-19.

  • Most COVID-19 positive deceased adults presented with symptoms typical of COVID-19, arguing that COVID-19 caused their deaths and was not a co-incidental finding.

  • Deaths occurred across the age spectrum, including among young children, indicating a different pattern of impact from what has been seen in high income country settings.

  • We document three waves of transmission, attributable to the AE.1 lineage, and the Beta and Delta variants, respectively.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The original ZPRIME study and this covid-19 expansion were made possible through the generous support of the Bill & Melinda Gates Foundation (OPP 1163027). The funders had no role in designing the study; in the collection and analysis of data; or in the decision to submit the article for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Boston University Medical Center gave ethical approval for this work Ethics committee/IRB of University of Zambia gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • We had inadvertantly ommitted two authors from the by line. The revision corrects this.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 22, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later
Christopher J Gill, Lawrence Mwananyanda, William MacLeod, Geoffrey Kwenda, Rachel Pieciak, Lauren Etter, Daniel J. Bridges, Chilufya Chikoti, Sarah Chirwa, Charles Chimoga, Leah Forman, Ben Katowa, Rotem Lapidot, James Lungu, Japhet Matoba, Gift Mwinga, Benjamin Mubemba, Zachariah Mupila, Walter Muleya, Mulenga Mwenda, Benard Ngoma, Ruth Nkazwe, Diana Nzara, Natalie Pawlak, Lillian Pemba, Ngonda Saasa, Edgar Simulundu, Baron Yankonde, Donald M. Thea
medRxiv 2022.03.08.22272087; doi: https://doi.org/10.1101/2022.03.08.22272087
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later
Christopher J Gill, Lawrence Mwananyanda, William MacLeod, Geoffrey Kwenda, Rachel Pieciak, Lauren Etter, Daniel J. Bridges, Chilufya Chikoti, Sarah Chirwa, Charles Chimoga, Leah Forman, Ben Katowa, Rotem Lapidot, James Lungu, Japhet Matoba, Gift Mwinga, Benjamin Mubemba, Zachariah Mupila, Walter Muleya, Mulenga Mwenda, Benard Ngoma, Ruth Nkazwe, Diana Nzara, Natalie Pawlak, Lillian Pemba, Ngonda Saasa, Edgar Simulundu, Baron Yankonde, Donald M. Thea
medRxiv 2022.03.08.22272087; doi: https://doi.org/10.1101/2022.03.08.22272087

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1435)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10334)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2654)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (681)
  • Hematology (269)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1335)
  • Ophthalmology (403)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2421)
  • Public and Global Health (5032)
  • Radiology and Imaging (902)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)